What Is a Normal DHEA-S Level in PCOS?

What Is a Normal DHEA-S Level in PCOS?

For most women with PCOS, a DHEA-S level below 200 µg/dL is considered reassuring, while values above 350 µg/dL are a clear signal of excess adrenal androgen activity. The main caveat: standard lab reference ranges span roughly 35–430 µg/dL for reproductive-age women, which means a result of 380 µg/dL can read as 'normal' on your report while still contributing to symptoms. Women with adrenal PCOS — a recognized subtype — often need a tighter functional threshold to guide treatment.

---

Why DHEA-S Matters in PCOS

Dehydroepiandrosterone sulfate (DHEA-S) is a sulfated steroid secreted almost exclusively by the adrenal cortex, making it a clean marker of adrenal androgen output. Unlike testosterone — which comes from both the ovaries and adrenals — DHEA-S reflects what your stress glands are doing. In PCOS, about 20–30% of cases are driven primarily by adrenal hyperandrogenism rather than ovarian androgens, a distinction that changes which interventions actually work (Carmina et al., Journal of Clinical Endocrinology & Metabolism 1992; PMID: 1548350).

DHEA-S also converts peripherally to testosterone and estrone, so chronically elevated levels add to the androgen burden even if your free testosterone looks borderline. This peripheral conversion is mediated by 17β-hydroxysteroid dehydrogenase and aromatase in tissues including skin, adipose, and liver, meaning women with higher body fat percentages may experience amplified androgenic effects even at moderately elevated DHEA-S levels. This is why women with acne, hair thinning, or irregular cycles can have a 'normal' testosterone but still benefit from addressing DHEA-S directly.

It is also worth noting that DHEA-S has a relatively long half-life of 7–10 hours compared to DHEA's 1–3 hours, making it the preferred clinical marker because it is far less subject to diurnal variation or acute stress spikes at the moment of blood draw. A single fasting morning measurement is generally reliable, whereas serum DHEA (unsulfated) fluctuates enough to create interpretation errors.

---

Reference Ranges vs. Functional Ranges: Understanding the Numbers

Standard laboratory reference intervals for DHEA-S in women aged 18–50 are broad by design — they capture 95% of a healthy population, including outliers on both ends.

The functional targets in the right column are drawn from endocrinology practice guidelines and research showing that PCOS symptom burden correlates more tightly with DHEA-S above 250–300 µg/dL than with whether a value technically falls inside the lab's reference band (Azziz et al., Fertility and Sterility 2004; PMID: 15482763).

It is important to understand that DHEA-S declines with age — a process called adrenopause — so a value of 280 µg/dL carries different clinical weight at age 22 versus age 44. Comparing your result against the age-stratified functional column, rather than a single flat cutoff, gives a more meaningful read. This is also why postpartum DHEA-S assessments can be tricky: levels naturally drop after delivery and then rebound, making timing of the blood draw critical. For a related look at postpartum hormone ranges, what is a normal DHEA-S level postpartum explains the expected trajectory and when to act.

If you've been told your DHEA-S is fine but your symptoms persist, asking your provider to interpret your result against the functional range — not just the population reference — is a reasonable next step. For context on how PCOS affects other hormonal markers, understanding what counts as a normal estradiol level in PCOS is equally important for piecing together the full hormonal picture.

---

What Causes Elevated DHEA-S in PCOS?

Several mechanisms drive adrenal androgen excess in PCOS:

1. HPA axis dysregulation — The hypothalamic-pituitary-adrenal (HPA) axis governs cortisol and DHEA-S simultaneously. Chronic psychological or physiological stress upregulates adrenal output of both hormones. In women with PCOS, HPA sensitivity to CRH (corticotropin-releasing hormone) is often amplified, producing higher DHEA-S for a given stressor (Azziz et al., NEJM 2006; PMID: 16510739).

1. Insulin resistance — Elevated insulin stimulates adrenal androgen synthesis independently of ACTH, partly by upregulating steroidogenic acute regulatory (StAR) protein expression in the adrenal cortex. This is why insulin-sensitizing strategies lower DHEA-S in some women with PCOS even without directly targeting the adrenals. If you want to understand what drives insulin dysregulation further, what causes fasting insulin to be out of range covers the key mechanisms in depth.

1. Dysregulated 3β-HSD enzyme activity — The enzyme 3β-hydroxysteroid dehydrogenase converts DHEA to androstenedione. In some women with adrenal PCOS, reduced 3β-HSD activity shunts more steroid flux toward DHEA and DHEA-S rather than downstream androgens, producing a characteristic pattern of elevated DHEA-S with relatively normal testosterone. This enzymatic pattern can be inherited and is not correctable by lifestyle alone — it often requires medical management.

1. Low-grade inflammation — Inflammatory cytokines (especially IL-6 and TNF-α) sensitize the adrenal cortex to ACTH, raising androgen output. C-reactive protein and IL-6 correlate with DHEA-S levels in cross-sectional studies of PCOS populations, supporting inflammation as an independent driver beyond HPA reactivity alone. This is increasingly recognized as a defining feature of the adrenal PCOS subtype.

1. Sleep disruption — Poor sleep quality raises morning cortisol and co-stimulates DHEA-S. Studies in women with PCOS confirm that sleep-disordered breathing is independently associated with higher androgen indices (Sam et al., Journal of Clinical Endocrinology & Metabolism 2012; PMID: 22170715). Even subclinical sleep fragmentation — without frank apnea — elevates morning cortisol area under the curve, which drags DHEA-S up with it.

---

How Stress Drives DHEA-S Elevations — and What to Do About It

Stress is one of the most consistent but underestimated triggers for elevated DHEA-S flare-ups in PCOS. The mechanism is direct: psychological stress activates the HPA axis, ACTH rises, and the adrenal cortex produces more cortisol and DHEA-S together. In women with adrenal PCOS, this stress-to-androgen pipeline is measurably more reactive than in women without PCOS — not because they handle stress worse as individuals, but because the adrenal cortex itself is sensitized at a cellular level.

Research using the Trier Social Stress Test has shown that PCOS subjects produce a significantly larger ACTH and cortisol response to standardized psychosocial stress than age-matched controls, with the cortisol response area under the curve roughly 40% higher in the adrenal PCOS subgroup. Because DHEA-S is co-regulated by ACTH, this means each stressful episode generates a proportionally larger adrenal androgen spike.

Practical strategies that have evidence behind them:

1. Prioritize sleep consistency — Going to bed and waking at the same time daily stabilizes the circadian rhythm that governs morning cortisol. Even one night of sleep deprivation raises next-day DHEA-S in healthy adults; chronic irregularity sustains the elevation.

1. Resistance training over chronic cardio — High-volume endurance exercise is itself a physical stressor that raises cortisol. Resistance training in moderate doses (2–4 sessions per week) improves insulin sensitivity and has a more favorable cortisol profile in women with PCOS. A 12-week resistance training intervention in women with PCOS demonstrated significant reductions in free androgen index alongside improvements in fasting insulin, suggesting the two drivers — insulin resistance and adrenal output — respond together.

1. Mindfulness-based stress reduction (MBSR) — An 8-week MBSR intervention reduced salivary cortisol and self-reported stress in randomized trials of adults with stress-related conditions, supporting its plausibility for PCOS-related HPA dysregulation. The effect on DHEA-S specifically has not been isolated in a large PCOS trial, but given the ACTH-mediated co-regulation, cortisol attenuation logically carries over.

1. Adaptogenic herbs — KSM-66 ashwagandha (600 mg/day) reduced serum cortisol by 27.9% versus placebo over 60 days in a double-blind, randomized trial of 64 chronically stressed adults (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). By dampening the cortisol-DHEA-S co-release dynamic, adaptogens may help reduce the adrenal androgen burden over time — though direct DHEA-S data in PCOS populations specifically are limited and more research is needed. Rhodiola rosea (typically 200–400 mg of a standardized 3% rosavins extract) has also shown cortisol-buffering properties in stressed adults in an open-label trial, though head-to-head data against ashwagandha in PCOS are lacking.

1. Blood sugar stability — Avoiding prolonged fasting and large glycemic spikes reduces reactive cortisol, which indirectly buffers adrenal androgen output. Eating balanced meals with adequate protein every 4–5 hours is a simple structural intervention that supports both insulin sensitivity and HPA stability simultaneously.

The psychological weight of living with PCOS symptoms — hair loss, acne, irregular cycles, fatigue — itself becomes a chronic stressor that perpetuates the HPA loop. Addressing that psychological burden is not separate from treating DHEA-S; it is part of the same intervention. Recognizing that your body's stress response is genuinely dysregulated at a physiological level — not a character flaw or anxiety problem — is the first step toward breaking the cycle deliberately.

---

DHEA-S, Vitamin D, and the Androgen Connection

Vitamin D deficiency is extremely common in PCOS — estimated to affect 67–85% of women with the condition in some populations. Lower vitamin D status is independently associated with higher androgen levels including DHEA-S, likely through its role in modulating adrenal 17α-hydroxylase activity and reducing pro-inflammatory cytokine signaling that sensitizes the adrenal cortex to ACTH. Correcting vitamin D deficiency has been shown to reduce total testosterone and improve menstrual regularity in vitamin D–deficient women with PCOS (Irani & Merhi, European Journal of Obstetrics & Gynecology 2014; PMID: 25028782).

The dose matters here. Studies showing meaningful hormonal benefit used 4,000–50,000 IU weekly — not the 600–800 IU that appears on most supplement labels. Correcting a genuine deficiency (25(OH)D below 20 ng/mL) to a sufficient range (40–60 ng/mL) is what moves the hormonal needle, which is why calibrating dose to actual serum levels rather than using a flat population dose is essential.

This relationship is one reason understanding what counts as a normal vitamin D level in PCOS is worth reading alongside your DHEA-S results — the two biomarkers are not independent, and treating them in isolation misses the mechanistic link between vitamin D status, adrenal sensitivity, and androgen output.

---

Does It Matter When You Take Supplements for Adrenal Support? DHEA With Food or Empty Stomach

For supplements targeting the HPA axis and adrenal androgens, timing and administration context can influence both tolerability and efficacy:

• Adaptogenic herbs (ashwagandha, rhodiola): Taking these with food reduces the risk of nausea and may modestly improve absorption of their active constituents. Rhodiola is sometimes recommended in the morning specifically because of its mild energizing effect — taking it late in the day may interfere with sleep in sensitive individuals. Ashwagandha, by contrast, has been used in evening protocols in some trials without sleep interference, suggesting individual variation matters more than a universal rule.

• DHEA supplements (note: distinct from DHEA-S): Over-the-counter DHEA supplementation is generally not recommended for women with PCOS who already have elevated DHEA-S, since it adds to an existing androgen excess. If a provider does prescribe low-dose DHEA for a different indication (for example, adrenal insufficiency or diminished ovarian reserve in a different clinical context), it is typically taken with food in the morning to align with the body's natural cortisol and DHEA peak.

• Vitamin D3 + K2: Fat-soluble vitamins are consistently better absorbed with a fat-containing meal. A study comparing vitamin D absorption in fed versus fasted states found a 50% increase in absorption when taken with the largest meal of the day (Mulligan & Licata 2010; PMID: 20200983). Pairing D3 with MK-7 (menaquinone-7) is clinically important for women on higher vitamin D doses because K2 directs calcium away from arteries and toward bone — an effect that becomes more significant as D3 doses rise above 2,000 IU.

• Zinc: Zinc picolinate taken on an empty stomach absorbs efficiently but can cause nausea in some people. Taking it with a small amount of food resolves most GI complaints without meaningfully reducing absorption. For a deeper look at this question, zinc picolinate with food or empty stomach covers the clinical trial data in detail. Zinc is particularly relevant to adrenal PCOS because it moderates 5α-reductase activity — the enzyme responsible for converting testosterone to the more potent DHT in skin and hair follicles.

The practical takeaway: for adrenal-supportive supplements, morning timing with food is a reasonable default that aligns with circadian androgen physiology and improves tolerability across most ingredient classes.

---

What This Means for Your Formula

If your DHEA-S is elevated and your bloodwork, wearable data, or symptom history suggests HPA axis dysregulation, the supplemental priorities shift toward adrenal modulation rather than generic hormone support. Here is how Ones approaches this specifically:

KSM-66 Ashwagandha (600 mg/day): Ones includes KSM-66 — the most clinically studied ashwagandha extract — at the 600 mg dose used in the Chandrasekhar 2012 trial that demonstrated a 27.9% reduction in serum cortisol over 60 days. This dose is included when the AI identifies signs of HPA hyperreactivity in a user's data, not applied universally across all PCOS profiles.

Adrenal Support (System Blend): Ones carries a proprietary Adrenal Support blend formulated to address the interconnected demands of the HPA axis — not a generic multivitamin add-on, but a targeted blend informed by clinical evidence for adrenal androgenic patterns. It is included specifically when the data pattern points to adrenal rather than ovarian androgen excess.

Vitamin D3 + K2 (MK-7): Given the strong inverse association between vitamin D status and adrenal androgen excess in PCOS, Vitamin D3 paired with K2 as MK-7 is included in formulas where low vitamin D is identified — at doses calibrated to the user's actual serum 25(OH)D result rather than a one-size-fits-all dose. This distinguishes a personalized protocol from a generic supplement stack.

Ones does not apply a templated PCOS formula. When lab results show elevated DHEA-S, normal testosterone, and signs of stress reactivity, the formula reflects that specific adrenal pattern rather than treating all PCOS presentations identically. The AI matches capsule selection to the specific hormonal fingerprint, which is why two women with PCOS can receive meaningfully different formulas.

---

Key Takeaways

• A DHEA-S below 200 µg/dL is generally reassuring in PCOS; values above 350 µg/dL are a clear signal of adrenal androgen excess, even if your lab report reads 'within range.'
• Standard reference ranges (35–430 µg/dL) are too wide to detect the mild-to-moderate elevations that drive PCOS symptoms — ask your provider to apply age-stratified functional thresholds.
• Elevated DHEA-S in PCOS is driven by HPA axis reactivity, insulin resistance, low-grade inflammation, sleep disruption, and reduced 3β-HSD enzyme activity — often in combination, not in isolation.
• Chronic stress is a primary trigger for DHEA-S flare-ups; HPA-targeted strategies (sleep consistency, resistance training, evidence-backed adaptogens) are first-line lifestyle interventions with measurable cortisol effect sizes.
• Vitamin D deficiency amplifies adrenal androgen output through multiple pathways; correcting it to 40–60 ng/mL — not just above the lab's deficiency cutoff — is where the hormonal benefit appears in trials.
• Supplement timing for adrenal support matters: fat-soluble vitamins with food, adaptogens in the morning, and OTC DHEA should generally be avoided when DHEA-S is already elevated.
• Consult a healthcare provider before starting or stopping any supplement, especially if you have a diagnosed endocrine condition.